Galapagos reported 4.75B in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
AstraZeneca AZN:LN 22.65B 3.6B
Biogen BIIB:US $ 7915.9M 59.4M
Genmab GEN:DC 23.18B 439M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
GRIFOLS GRF:SM € 3239.5M 153.93M
H. Lundbeck A/S LUN:DC 9.04B 432M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Merck MRK:GR € 11085M 103M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
YTE INCY:US $ 3288.09M 169.42M